Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1486-1491

  Lambourne, Jonathan ^a   Agranoff, Dan ^b   Herbrecht, Raoul ^h   Buchbinder, Aby ^j   Willis, Fenella ^a   Letscher Bru, Valérie ⁱ   Agrawal, Samir ^c,d   Doffman, Sarah ^c,d   Johnson, Elizabeth ^e   White, P Lewis ^f   Barnes, Rosemary A ^g   Griffin, George ^a   Lindsay, Jodi A ^a   Harrison, Thomas S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h HÔPITAL DE HAUTEPIERRE   (France)

ⁱ Institut de Parasitologie et de Pathologie Tropicale   (France)

^j Enzon Incorporated   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN; ITRACONAZOLE; MANNOSE BINDING LECTIN; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; TREATMENT RESPONSE;

ADULT; ANIMALS; ASPERGILLOSIS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PREVALENCE;

EID: 72849125338     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644619     Document Type: Article

References (46)

1. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-415 (Pubitemid 34851833) (Pubitemid 34851833)
2. Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47:1176-1184
3. Wingard JR, Ribaud P, Schlamm HT, Herbrecht R. Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 2008; 112:2309-2312 (Pubitemid 351628643) (Pubitemid 351628643)
4. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173:707-717
5. Gravelat FN, Doedt T, Chiang LY, et al. In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 2008; 76:3632-3639
6. Iobst ST, Wormald MR, Weis WI, Dwek RA, Drickamer K. Binding of sugar ligands to Ca(2+)-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR. J Biol Chem 1994; 269:15505-15511
7. Weis WI, Drickamer K. Trimeric structure of a C-type mannose-binding protein. Structure 1994; 2:1227-1240 (Pubitemid 124001321)
8. Ohta M, Okada M, Yamashina I, Kawasaki T. The mechanism of car bohydrate-mediated complement activation by the serum mannanbinding protein. J Biol Chem 1990; 265:1980-1984 (Pubitemid 20248297)
9. Malhotra R, Thiel S, Reid KB, et al. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990; 172:955-959 (Pubitemid 20301242) (Pubitemid 20301242)
10. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56:630-641 (Pubitemid 35454347) (Pubitemid 35454347)
11. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155:3013-3020
12. Perez-Castellano M, Penaranda M, Payeras A, et al. Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 2006; 145:228-234 (Pubitemid 44060112) (Pubitemid 44060112)
13. Dean MM, Minchinton RM, Heatley S, Eisen DP. Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol 2005; 25:346-352 (Pubitemid 41204259) (Pubitemid 41204259)
14. Dumestre-Perard C, Lamy B, Aldebert D, et al. Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism. J Immunol 2008; 181:7100-7105
15. Wang Y, Liu T, Gong H, et al. Gene profiling in murine corneas challenged with Aspergillus fumigatus. Mol Vis 2007; 13:1226-1233 (Pubitemid 47091391)
16. Seyfarth J, Garred P, Madsen HO. Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol 2006; 43:962-971 (Pubitemid 41814413) (Pubitemid 41814413)
17. Ytting H, Christensen IJ, Thiel S, et al. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol 2007; 66:458-464 (Pubitemid 47394561) (Pubitemid 47394561)
18. Homann C, Garred P, Hasselqvist P, Graudal N, Thiel S, Thomsen AC. Mannan-binding protein and complement dependent opsonization in alcoholic cirrhosis. Liver 1995; 15:39-44.
19. Walsh MC, Shaffer LA, Guikema BJ, et al. Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage. J Immunol Methods 2007; 323:147-159
20. Thiel S, Frederiksen PD, Jensenius JC, Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006; 43:86-96. (Pubitemid 41021525)
21. Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, Turner MW. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992; 1:709-715
22. Neth O, Hann I, TurnerMW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614-618 (Pubitemid 32786825) (Pubitemid 32786825)
23. Schlapbach LJ, Aebi C, Otth M, et al. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 2007; 49:11-16 (Pubitemid 46847063) (Pubitemid 46847063)
24. Vekemans M, Robinson J, Georgala A, et al. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis 2007; 44:1593-1601 (Pubitemid 46871506) (Pubitemid 46871506)
25. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358:637-638 (Pubitemid 32786831) (Pubitemid 32786831)
26. Frakking FN, van de Wetering MD, Brouwer N, et al. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 2006; 42:909-916
27. Bergmann OJ, Christiansen M, Laursen I, et al. Low levels of mannosebinding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003; 70:91-97 (Pubitemid 36269555) (Pubitemid 36269555)
28. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693 (Pubitemid 30056524) (Pubitemid 30056524)
29. Davies J, Neth O, Alton E, Klein N, Turner M. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet 2000; 355:1885-1886 (Pubitemid 30311884)
30. Johnston IR. The composition of the cell wall of Aspergillus niger. Biochem J 1965; 96:651-658
31. Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007; 148:382-389 (Pubitemid 46587595) (Pubitemid 46587595)
32. Granell M, Urbano-Ispizua A, Suarez B, et al. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol 2006; 34:1435-1441 (Pubitemid 44374841) (Pubitemid 44374841)
33. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184:653-656
34. Gomi K, Tokue Y, Kobayashi T, et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 2004; 126:95-99 (Pubitemid 38943123) (Pubitemid 38943123)
35. Petersen KA, Matthiesen F, Agger T, et al. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2006; 26:465-475 (Pubitemid 44440180) (Pubitemid 44440180)
36. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14. (Pubitemid 33152659) (Pubitemid 33152659)
37. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
38. Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis 2008; 47:674-683
39. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006; 42:479-486
40. Frederiksen PD, Thiel S, Jensen L, Hansen AG, Matthiesen F, Jensenius JC. Quantification of mannan-binding lectin. J Immunol Methods 2006; 315:49-60.
41. Hope WW, Kruhlak MJ, Lyman CA, et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007; 195:455-466
42. Bellocchio S, Moretti S, Perruccio K, et al. TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173:7406-7415 (Pubitemid 39628180)
43. Serrano-Gomez D, Dominguez-Soto A, Ancochea J, Jimenez-Heffernan JA, Leal JA, Corbi AL. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol 2004; 173:5635-5643 (Pubitemid 39392151)
44. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001; 184:1152-1162 (Pubitemid 33010468) (Pubitemid 33010468)
45. Ip WKE, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RAB. Mannosebinding lectin enhances Toll-like receptors 2 and 6 signalling from the phagosome. J Exp Med 2008; 205:169-181 (Pubitemid 351185724) (Pubitemid 351185724)
46. Fidler KJ, Hilliard TN, Bush A, et al. Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax 2009; 64:150-155